China Continues as an Attractive Investment Destination
The 208-page bilingual 2025 Special Report on the State of the Business in
According to the 2025 Special Report on the State of Business in
Dr.
In 2024,
Key Takeaways of the 2025 Special Report on the State of Business in
- The proportion of companies that gained over 60% of their global revenue from
China has risen by 5 percentage points (pp) to 31%. - 47% of the companies studied experienced a significant or slight increase in revenue in
China . A larger share of American companies (43%, +7pp y-o-y) and manufacturing companies (47%, +17pp y-o-y) experienced revenue growth. - In 2024, overall profitability declined, with 85% of companies reporting profitability in
China , a 3pp decrease compared to the previous two years. - Concerning the companies that are profitable in
China , 45% reported to have met their budget expectations. Among companies yet to make profits inChina , 88% expect to reach that milestone within two to five years. Only 8% anticipate it will take more than six years. - In 2024, 57% of the companies studied remain optimistic about their business prospects in
China , a 5pp decrease from the previous year. American companies' confidence dropped by 14pp, while the manufacturing sector saw the steepest decline, with an 18pp drop in optimism. - In 2024, 61% of the companies studied reported to have reinvested in
China , marking a 5pp decline compared with the previous year. The reinvestment trend remains consistent for American companies, with 57% reporting to have actually reinvested inChina , in line with last year's figures. - 3% of the companies studied had each budgeted to reinvest
US$250 million or more inChina in 2024, while this year's findings reveal that 7% had actually followed through with reinvestments of this magnitude. - 59% of the companies studied have plans to expand their operations in
China over the coming three years. Guangzhou has been ranked as the top investment destination inChina for eight consecutive years, followed byShenzhen ,Shanghai , andBeijing .- Fierce local competition remains the greatest challenge faced by the companies studied in
South China , followed by rising labor costs and rising operation costs. - Not a single company indicated a complete withdrawal from the Chinese market. 91% of the companies studied assert that they will not decouple from the Chinese market due to the US-China trade tensions, a 5pp increase from 2023.
- One quarter of the companies studied are bullish about the US-China relations in the coming year, a significant decrease of 19pp compared to previous assessments.
The negative effects of both US and Chinese tariffs on the companies studied have been somewhat alleviated. Many companies have found ways to mitigate the impact through supply chain adjustments, strategic sourcing, or absorbing some of the tariff costs.
Dr. Seydin remarked, "American companies have long recognized the importance of the strong economic relationship between the two countries, and they remain committed to the mutual benefits of innovation, job creation, and cultural exchange that this partnership fosters. It is essential that both governments work together to create a more predictable and supportive trade environment where American businesses can continue to thrive and contribute to the long-term economic growth of both countries."
Special Report on the State of Business in
The Special Report on the State of Business in
The document can be downloaded free of charge from the chamber's website at http://www.amcham-southchina.com/amcham/static/publications/specialreport.jsp
About the American Chamber of Commerce in
The American Chamber of Commerce in
View original content to download multimedia:https://www.prnewswire.com/news-releases/china-continues-as-an-attractive-investment-destination-302385788.html
SOURCE The American Chamber of Commerce in
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PG&E Monitoring High Wind Event, Is Preparing for Possible Public Safety Power Shutoff for Portions of 10 Counties
- Monport Highlights the Growing Shift from Hobby Lasers to Production-Ready Desktop CO2 Laser Systems with the MEGAS
- Kelun-Biotech Announces Phase III Study of Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-Line Treatment for PD-L1-Negative Non-Squamous NSCLC Met Primary Endpoint
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share